In view of potential biotechnological applications, eukaryotic metallothion
eins (MTs) have been expressed in Escherichia coli as fusions to membrane o
r membrane-associated proteins such as LamB, the peptidoglycan-associated l
ipoprotein protein (PAL) or a hybrid Lpp/OmpA carrier sequence. The use of
different anchors enables the MT moiety to be targeted into various cell co
mpartments thus bringing the metal-binding ability of the resulting hybrids
to specific sites of the cell structure. To this end, both full-size and p
artial sequences of the human or mouse MTs have been genetically fused to:
i) the permissive site 153 of the LamB sequence, which loops out the MT to
the external medium; ii) the N-terminus of a PAL variant devoid of its N-te
rminal cystein, which targets expression of the fusion into the periplasm;
and iii) the C-terminus of Lpp-OmpA, for anchoring the MT to the outer memb
rane protein as an N-terminal fusion. Each type of fusion presented a disti
nct behavior in terms of expression, stability and ability to endow E. coli
cells an enhanced accumulation of Cd2+, in good correlation with the numbe
r of metal-binding centers contributed by the MT moiety of the fusions. The
expression in vivo of metalloproteins bound to bacterial envelope structur
es opens a way to design biomass with specific metal-binding properties. (C
) Societe francaise de biochimie et biologie moleculaire / Elsevier, Paris.